Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Current Topics in Microbiology and Immunology|December 15, 2012
Botulinum toxin: application, safety, and limitationsHans BigalkeJournal of Neural Transmission (Vienna, Austria : 1996)|April 22, 2016
Reconstituting botulinum toxin drugs: shaking, stirring or what?Dirk Dressler, Hans BigalkeJournal of Neural Transmission (Vienna, Austria : 1996)|August 4, 2017
Long-term stability of reconstituted incobotulinumtoxinA: how can we reduce costs of botulinum toxin therapy?Dirk Dressler, Hans BigalkeExpert Review of Neurotherapeutics|November 18, 2016
Immunological aspects of botulinum toxin therapyDirk Dressler, Hans BigalkeEuropean Neurology|October 14, 2004
Antibody-induced failure of botulinum toxin type B therapy in de novo patientsDirk Dressler, Hans BigalkeJournal of Neurology|March 12, 2005
Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failureDirk Dressler, Hans BigalkeMovement Disorders : Official Journal of the Movement Disorder Society|February 9, 2002
Botulinum toxin antibody type A titres after cessation of botulinum toxin therapyDirk Dressler, Hans BigalkeToxins|November 28, 2015
Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN)Hans Bigalke, Andreas RummelMovement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Pharmacokinetic properties of different formulations of botulinum neurotoxin type AKai Wohlfarth, Knut Kampe, Hans BigalkePageof 6